Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.



Welcome to the PANCAID blog, where we will be sharing updates, insights, and news about our efforts to improve early detection and diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC), the second leading cause of cancer-related death in Western societies. Our mission is to establish a minimally-invasive blood-based test for the early detection of PDAC.

  • World Pancreatic Cancer Day

    Today, 14th November, marks a significant day globally — World Pancreatic Cancer Day. It’s a day initiated by the World Pancreatic Cancer Coalition and dedicated to raising awareness about pancreatic cancer, an illness often diagnosed in its advanced stages and known for its low survival rates.

    Key Facts:

    1. Silent Threat: Pancreatic cancer is often called a “silent” disease because its symptoms can be subtle and easily attributed to other causes. This underscores the importance of paying attention to one’s body and seeking medical attention for persistent or unusual symptoms.
    2. Low Survival Rates: Pancreatic cancer has one of the lowest survival rates among major cancers. This emphasizes the urgency of early detection and underscores the need for continued research to develop more effective treatment strategies.
    3. Risk Factors: Understanding the risk factors associated with pancreatic cancer, such as family history, smoking, and certain genetic conditions, is crucial. Lifestyle changes and regular health check-ups can contribute to early intervention.

    We aim to take on the the biggest challenge in the clinical management of pancreatic cancer: the current inability to diagnose it in time. Read more on our research approach here.